S1PR2 and neuroblastoma: Moreover, we provide experimental evidence that SK2/S1P2 axis is responsible for β3-AR-dependent effects in NB and provide the molecular rationale to consider β3-AR/SK2/S1P2 as a promising therapeutic target for NB treatment.